Natural Treatments for the Management of Emotional Dysregulation in Youth With Non-verbal Learning Disability (NVLD) and/or Autism Spectrum Disorders (ASD)

• Status: Recruiting
• Trial end date: 2021-12-01

Summary

This study consists of a 6-week, open-label, randomized clinical trial study to compare efficacy and tolerability of the natural treatments omega-3 fatty acids, inositol, and N-acetylcysteine (NAC) in the treatment of mood dysregulation in children and adolescents with non-verbal learning disability (NVLD) or Autism Spectrum Disorder (ASD). Subjects will include youth ages 5-17 years with a non-verbal learning disability (NVLD) or autism spectrum disorder (ASD) and current symptoms of emotional dysregulation.

• Phase: Phase 4

Details

• Lead Sponsor: Massachusetts General Hospital
• Collaborator: Demarest Lloyd Jr. Foundation
• Treatments: Acetylcysteine; Inositol; N-monoacetylcystine